Mike Bower

Mike Bower is an accomplished computational chemist with extensive experience in drug discovery and development spanning over two decades. Currently serving as Associate Director at Delix Therapeutics, Mike Bower focuses on data analysis and cheminformatics for novel neuroplastogens. Prior to this role, Mike Bower was Principal Computational Chemist at Reverie Labs, leading oncology discovery projects and a computational chemistry team. Previous positions include Senior Research Scientist at Vertex Pharmaceuticals, where Mike Bower specialized in virtual screening, and Associate Director at Incyte Corporation, where Mike Bower established a computational research group. Additionally, Mike Bower has academic experience as an adjunct professor at both Delaware State University and the University of Delaware. Educational credentials include a PhD in Pharmaceutical Chemistry from the University of California, San Francisco, and a Bachelor of Science in Chemistry from the University of Delaware.